Investor's Champion

Objective, incisive company comment

Download a sample

Register now

Looking for refreshing forthright commentaries on quoted companies?

Company research

Latest IS Pharma comment

IS Pharma

January 26 2009
Featured in the small cap review:
A second batch of ‘AIM for IHT’ stock considerations from 2008 with H (H&T Group) to L (James Latham). Quite by accident another pawnbroker leads the way!

Login to purchase or download.

More on IS Pharma

TypeSummary 
Blog
Published: 02/06/2010
IS Pharma plc (AIM: ISPH), results marginally miss estimates but no big deal in the grand scheme
Blog
Published: 30/04/2010
IS Pharma (LON:ISPH)
Blog
Published: 04/03/2010
IS Pharma (LON:ISPH) snaps up the rights to Episil
Blog
Published: 23/11/2009
IS Pharma : Variquel® approval and management continues to shine
Small cap review
Published: 26/01/2009
A second batch of ‘AIM for IHT’ stock considerations from 2008 with H (H&T Group) to L (James Latham). Quite by accident another pawnbroker leads the way! Login to purchase or download.
Small cap review
Published: 12/09/2008
TOROTRAK The technology with this one may be great, but without any idea what the earnings potential is there is no way to gauge what premium (if any) the shares should be on to the net cash in the balance sheet – can anyone help the Champion? Login to purchase or download.
Small cap review
Published: 13/06/2008
Poor old Chamberlin! Its foundry has been around since 1890 and now it is subject to a ‘nuisance claim’ from a new housing development. No wonder British industry has a tough time Login to purchase or download.

All companies